DEFA14A: Allurion Clarifies Proxy Voting Rules for 2025 Annual Meeting
Proxy Statement Supplement
Allurion Technologies, Inc. issued a supplement to its 2025 proxy statement, clarifying routine and non-routine proposals for broker voting at the upcoming Annual Meeting.
Summary
- A supplement to the definitive proxy statement (Schedule 14A) was filed on November 25, 2025, amending and supplementing the original filing from November 24, 2025.
- The primary purpose of this supplement is to clarify the classification of proposals as routine or non-routine for purposes of broker non-votes at the 2025 Annual Meeting of Stockholders.
- Proposals 1, 3, 4, 5, and 6 are designated as non-routine matters, meaning brokers cannot vote shares held in street name on these proposals without specific instructions from the beneficial owner.
- Proposals 2, 7, and 8 are designated as routine matters, allowing brokers to vote shares in their discretion if no voting instructions are received from the beneficial owner by the broker's deadline.
- The Annual Meeting of Stockholders is scheduled to be held on December 18, 2025, at 12:00 p.m. Eastern Time.
- No changes have been made to the proposals themselves, and any proxy voting instructions already submitted by stockholders remain valid unless revoked.
Sentiment
Score: 5
Explanation: Neutral, as this is an administrative clarification of voting procedures, not an operational or financial update that would typically impact sentiment positively or negatively.
Future Outlook
NA
Management Comments
- As a stockholder, your vote is very important, and the Board of Directors encourages you to exercise your right to vote whether or not you plan to attend the Annual Meeting.
Industry Context
This administrative update is a standard corporate governance practice to ensure clarity in proxy voting procedures, particularly concerning broker discretion for routine and non-routine matters, and does not relate to broader industry trends or competitive positioning.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Clarification of Voting Rules | Amended disclosure regarding the classification of proposals as routine and non-routine for purposes of broker non-votes, affecting how shares held in street name are voted at the Annual Meeting. | November 25, 2025 | Enhances transparency and clarity for brokers and beneficial owners regarding voting procedures, potentially reducing confusion and ensuring that shareholder intentions are accurately reflected, especially for non-routine matters requiring specific instructions. |
Stakeholder Impact
- Shareholders: Provides clearer guidance on how their votes will be handled by brokers, particularly for non-routine matters, ensuring their voting intentions are accurately reflected.
Next Steps
- Stockholders are urged to read the Proxy Statement and this Supplement carefully in deciding how to vote.
- Stockholders are encouraged to exercise their right to vote at the Annual Meeting on December 18, 2025.
Key Dates
| Date | Description |
|---|---|
| November 24, 2025 | Original definitive proxy statement (Schedule 14A) filed with the SEC. |
| November 25, 2025 | Date of this Supplement to the Proxy Statement. |
| December 18, 2025 | Date of the 2025 Annual Meeting of Stockholders. |
Recommendation
holdThe filing is an administrative supplement clarifying proxy voting procedures and does not contain any new financial, operational, or strategic information that would warrant a change in investment recommendation. It is a routine corporate governance update.
Keywords
Allurion Technologies, Proxy Statement, Annual Meeting, Shareholder Vote, Corporate Governance, Broker Non-Votes, SEC Filing, DEFA14A
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.